Ameriprise
KITE

Ameriprise’s Kite Pharma, Inc. KITE Stock Holding History

Ameriprise’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$36K – 3822
2017
Q3 		$36K Buy
+200
New +$27.9K ﹤0.01% 3643

Ameriprise's KITE Position: Q4 2017 in Review

Ameriprise sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 10,209 shares — an estimated $1.84M sold.

Ameriprise first reported a position in KITE in Q4 2014 and held it in 11 quarters. The position peaked at $8.98M in Q1 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Ameriprise reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Ameriprise sold 10,209 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.84M.
  • Ameriprise first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 11 quarters.
  • Ameriprise's Kite Pharma, Inc. position peaked at $8.98M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Ameriprise's 13F filing for Q4 2017, filed 12 Feb 2018.